ZNF25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.804420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.467400E-01
Normal-vs-Stage2
1.000570E-01
Normal-vs-Stage3
4.697700E-02
Normal-vs-Stage4
7.101600E-01
Stage1-vs-Stage2
7.344100E-02
Stage1-vs-Stage3
1.376990E-01
Stage1-vs-Stage4
8.413600E-01
Stage2-vs-Stage3
2.737400E-01
Stage2-vs-Stage4
2.723400E-01
Stage3-vs-Stage4
2.055200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.006000E-01
Normal-vs-AfricanAmerican
1.764040E-01
Normal-vs-Asian
4.840100E-02
Caucasian-vs-AfricanAmerican
7.223000E-01
Caucasian-vs-Asian
1.264050E-01
AfricanAmerican-vs-Asian
4.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.797830E-01
Normal-vs-Female
2.004000E-01
Male-vs-Female
6.126400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.441000E-01
Normal-vs-Age(41-60Yrs)
3.533400E-01
Normal-vs-Age(61-80Yrs)
1.541640E-01
Normal-vs-Age(81-100Yrs)
1.913970E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.086600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.170000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.302300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.515900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.760000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.561900E-02
Normal-vs-Daily Drinker
4.175700E-02
Normal-vs-Weekly Drinker
1.310840E-01
Normal-vs-Occasional Drinker
2.097800E-01
Normal-vs-Social Drinker
8.060000E-01
Non Drinker-vs-Daily Drinker
7.947000E-01
Non Drinker-vs-Weekly Drinker
4.213000E-01
Non Drinker-vs-Occasional Drinker
1.839980E-01
Non Drinker-vs-Social Drinker
5.736000E-02
Daily Drinker-vs-Weekly Drinker
5.636000E-01
Daily Drinker-vs-Occasional Drinker
2.876400E-01
Daily Drinker-vs-Social Drinker
7.756200E-02
Weekly Drinker-vs-Occasional Drinker
6.897600E-01
Weekly Drinker-vs-Social Drinker
1.737250E-01
Occasional Drinker-vs-Social Drinker
2.675000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.569640E-01
Normal-vs-Grade 2
7.126000E-02
Normal-vs-Grade 3
1.072750E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.107200E-01
Grade 1-vs-Grade 3
5.234400E-01
Grade 1-vs-Grade 4
1.569640E-01
Grade 2-vs-Grade 3
4.357800E-01
Grade 2-vs-Grade 4
7.126000E-02
Grade 3-vs-Grade 4
1.072750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.292300E-02
Normal-vs-NonDiabetic
1.234580E-01
Diabetic-vs-NonDiabetic
7.533200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.021900E-02
Normal-vs-NoPancreatitis
1.317400E-01
Pancreatitis-vs-NoPancreatitis
5.776000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.854200E-01
Normal-vs-N1
9.528100E-02
N0-vs-N1
2.386200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.882400E-02
Normal-vs-TP53-NonMutant
4.882000E-01
TP53-Mutant-vs-TP53-NonMutant
5.142700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
